VCM
BIVV

Versant Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Versant Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-117
Closed -$6K – 1765
2017
Q4 		$6K Hold
117
– – ﹤0.01% 1103
2017
Q3 		$6K Hold
117
– – ﹤0.01% 1031
2017
Q2 		$7K Hold
117
– – ﹤0.01% 986
2017
Q1 		$6K Buy
+117
New +$5.76K ﹤0.01% 1019

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Versant Capital Management's BIVV Position: Q1 2018 in Review

Versant Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 117 shares — an estimated $6K sold.

Versant Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Versant Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Versant Capital Management sold 117 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6K.
  • Versant Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Versant Capital Management's Bioverativ Inc. Common Stock position peaked at $7K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Versant Capital Management's 13F filing for Q1 2018, filed 19 Apr 2018.